{
  "report_rows": [
    {
      "kpi": "Q3 net sales",
      "prediction": "BEAT",
      "answer": "pred ~$2.70B vs. cons $2.66B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 EBITDA As Defined",
      "prediction": "BEAT",
      "answer": "pred ~$1.42B vs. cons $1.39B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$10.42 vs. cons $10.15",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Net sales guidance",
      "prediction": "BETTER",
      "answer": "guide ~$10.50B vs. cons $10.40B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "EBITDA As Defined guidance",
      "prediction": "BETTER",
      "answer": "guide ~$5.50B vs. cons $5.44B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$40.45 vs. cons $40.08 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The FY2026 adjusted EPS guide of ~$40.45 vs. consensus $40.08 implies Q4 adjusted EPS of roughly $11.94 vs. consensus $11.66 after the predicted Q3 result, supporting positive estimate revisions rather than an earnings-day fade.",
  "day5_confidence": "MEDIUM"
}